Evidence map›Paper›PMID 36990606›Full record

ArticleThe Lancet. Oncology2023

Endoscopic surveillance: time for a paradigm shift in hereditary diffuse-type gastric cancer management?

Rachel Sophia van der Post, Tanya Maria Bisseling, Jolanda Marianne van Dieren

Abstract readComment
PubMed Publisher
In one paragraph

Article in The Lancet. Oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Predictors of early cancer burden inEClinicalMedicine · 2026
    Article
  3. Mapping the genetic landscape of hereditary diffuse-type gastric cancer progression.Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association · 2026
    Article
  4. Review
  5. Article
  6. Hereditary diffuse gastric cancer: the evolution of a cancer syndrome.Journal of the Royal Society of New Zealand · 2025
    Review
  7. Review
  8. Article
  9. Review
  10. Case Series of 11Genes · 2023
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Rachel Sophia van der PostDepartment of Pathology, Radboud University Medical Centre, Nijmegen 6525 GA, Netherlands. Electronic address: chella.vanderpost@radboudumc.nl.
Tanya Maria BisselingDepartment of Gastroenterology, Radboud University Medical Centre, Nijmegen 6525 GA, Netherlands.
Jolanda Marianne van DierenDepartment of Gastrointestinal Oncology, The Netherlands Cancer Institute, Amsterdam, Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdenocarcinomaStomach NeoplasmsEndoscopyGastrectomyGenetic Predisposition to DiseaseGerm-Line MutationHumans

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.